In vitro, SERPINB2-deficient cancer cells are associated with increased tumor growth, aberrant ECM, and invasive properties, while SERPINB2 overexpression inhibits tumor proliferation and migration [57, 58]. The gene discussed is SERPINB2; the disease is cancer.